Cipta Sarana Medika Tbk. vs Summarecon Agung Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Summarecon Agung Tbk. trades at Rp290 (market cap 4.79T, 8.87M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 30.3× Cipta Sarana Medika Tbk.'s market cap, and Summarecon Agung Tbk. is more actively traded (8.87M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | SMRA | |
|---|---|---|
Market Cap | 158.12B | 4.79T |
Volume | 8.21M | 8.87M |
Lot | 82.15K | 88.74K |
Turnover | 515.2M | 2.58B |
Average Price | 62.72 | 291.2 |
Value | 515.2M | 2.58B |
Indicative Equilibrium Price | 63 | 290 |
Indicative Equilibrium Volume | 1.33K | 866 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →